As the tools and technologies that are available to study the skin microbiome become cheaper and more accessible, the fundamental mechanisms that link the skin microbiome with skin health are becoming stronger. The demand for skin microbiome products is advancing rapidly which is only being reflected in the increasing number of products on the market...

Extractable compounds with unknown identities are a common problem when conducting a chemical characterization study in support of medical device biocompatibility. With increasing instrument sensitivity, regulatory scrutiny, and the widespread adoption of the Analytical Evaluation Threshold (AET), unknown compounds are being seen in increasing number in many studies. Many manufacturers struggle to address and mitigate...

Attend the 3rd Annual Diversity, Equity & Inclusion Forum: Perspectives & Possibilities for the Life Science Industry. This virtual event will be held Tuesday, December 8 and will bring together leaders and decision makers in our industry for a solution-focused discussion on how to best drive action and create positive change. In addition to our keynote and Impact...

MedCity INVEST Precision Medicine is an executive program that gathers all sectors of healthcare to provide the most accurate picture of the future of precision medicine. Precision medicine is the next chapter of healthcare and life sciences promising more targeted, effective treatment and cures for common and rare diseases. But with advancements in digital health,...

Natural killer (NK) cells are highly effective and fast-acting cytolytic cells capable of eradicating target cells with limited adverse effects. Nkarta Therapeutics is focused on developing the next generation of "off-the-shelf" cell therapy product using its proprietary and scalable NK cell expansion platform that allows us to enhance the power, applicability and tolerability of NK...